Market Overview

Sunshine Heart Names Eric Lovett as VP, Clinical Affairs

Share:

Sunshine Heart, Inc. (Nasdaq: SSH) today announced the appointment of Eric Lovett Ph.D., to the position of Vice President, Clinical Affairs. In this capacity, Dr. Lovett will manage the Company's U.S. pivotal study (COUNTER HF™) for its flagship C-Pulse® Heart Assist System, a medical device designed to treat patients with moderate to severe heart failure.
"Eric brings to the Company a broad range of experiences in new ventures as well as large companies. Having led organizations from discovery through clinical evaluation and product launch, Eric's broad experience is extremely valuable to an emerging company such as Sunshine Heart," said John Erb, Chairman and Interim Chief Executive Officer of Sunshine Heart. Dr. Lovett has been involved in the design, execution and administration of clinical studies for over 25 years. Prior to joining Sunshine Heart, Dr. Lovett was Vice President of Research and Innovation at CVRx, Inc. where he spent the last eight years. CVRx, Inc. is a privately held company working on implantable technology for the treatment of hypertension and heart failure. Prior to CVRx, Dr. Lovett worked for eight years at Guidant Corporation (later Boston Scientific,

See full press release

 

Related Articles (SSH)

View Comments and Join the Discussion!

Posted-In: News Management Press Releases